This is an old revision of this page, as edited by Beetstra (talk | contribs) at 13:50, 10 January 2012 (Saving copy of the {{drugbox}} taken from revid 464802257 of page Trastuzumab for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:50, 10 January 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 464802257 of page Trastuzumab for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This page contains a copy of the infobox ({{drugbox}}) taken from revid 464802257 of page Trastuzumab with values updated to verified values. |
 | |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | HER2/neu |
| Clinical data | |
| Trade names | Herceptin |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | Intravenous |
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Unknown, possibly reticuloendothelial system. |
| Elimination half-life | 2-12 days |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6470H10012N1726O2013S42 |
| Molar mass | 145531.5 g/mol g·mol |
| (what is this?) (verify) | |
